Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 806

Results For "CE"

9359 News Found

RNAGene and PharmAbcine to develop novel mRNA therapeutics
Biotech | March 21, 2022

RNAGene and PharmAbcine to develop novel mRNA therapeutics

mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody


Genomic data opened to researchers
Public Health | March 21, 2022

Genomic data opened to researchers

All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform


Mylab to open new facility in Vishakhapatnam
News | March 21, 2022

Mylab to open new facility in Vishakhapatnam

Spread over 43,000 square feet, the facility will be set up to cater to the increasing demand for transformative molecular testing in India and across the world for early and accurate diagnosis


Hetero gets CDSCO approval to manufacture and sell Sputnik Light in India
News | March 21, 2022

Hetero gets CDSCO approval to manufacture and sell Sputnik Light in India

Sputnik Light is the first component of Sputnik V


Aesculap launches new sterile container system
Packaging | March 19, 2022

Aesculap launches new sterile container system

The system boasts features that help streamline processes in the SPD and OR and reduce the possibility of wet sets.


Govt to deploy Truenat platform for TB screening across India
News | March 19, 2022

Govt to deploy Truenat platform for TB screening across India

It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour


Manipal Hospitals deploys wearable technology to monitor post-surgery care
Hospitals | March 19, 2022

Manipal Hospitals deploys wearable technology to monitor post-surgery care

Manipal Hospitals partners with ConnectedLife, leveraging Fitbit wearable technology, for Continuity of Care Post-High-Risk Surgeries built with Google Cloud


USFDA approves Opdualag to treat metastatic melanoma
Drug Approval | March 19, 2022

USFDA approves Opdualag to treat metastatic melanoma

Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab


Tata Elxsi has unveiled TEngage, a digital health platform
Digitisation | March 19, 2022

Tata Elxsi has unveiled TEngage, a digital health platform

In contrast to the digital health solutions in the market, TEngage is cloud-based, fully customizable and allows hospitals to implement modules with just the required features, keeping the deployment and operational cost in check


USFDA approves Marinus’ treatment for genetic disorder
Drug Approval | March 19, 2022

USFDA approves Marinus’ treatment for genetic disorder

First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older